Search results
NBA Slams Warner Bros Discovery Suit Over TV Rights As “Without Merit”; Media Giant Accuses League...
Deadline via Yahoo Finance Canada· 2 hours ago(Updated with NBA statement) Just hours before the Opening Ceremony is set to kick off in Paris,...
What the NBA’s Media Rights Deal Means For the League’s Future
GiveMeSport· 2 hours agoThe NBA has officially agreed with Amazon on a new media rights deal, ending its current...
Germany's Merck raises 2024 forecast on healthcare, electronics units' performance
Reuters via Yahoo Finance Canada· 2 hours agoThe maker of pharmaceuticals, lab gear and specialty chemicals now expects net sales to be between...
Warner Bros Discovery sues NBA over bid for broadcast rights
Reuters via Yahoo Finance Canada· 2 hours agoThe media company accused the NBA of breaching its agreement in refusing to honor its right to match...
GM Arlington Assembly rolls out its 13 millionth vehicle: A $150,000 Cadillac Escalade-V
Fort Worth Star-Telegram via Yahoo Finance Canada· 2 hours agoIn June 2023, GM announced plans to invest $500 million in the Arlington Assembly facility. The...
Charles Barkley to entertain deals if TNT doesn't honor contract
New York Times· 2 hours ago“My deal is 10 years, $210 million,” Barkley said in a phone interview. The NBA announced this week...
Wall Street Banks Amp Up Rate Risk on Preferred Share Sales
Bloomberg via Yahoo Finance Canada· 2 hours ago(Bloomberg) -- Morgan Stanley and Citigroup Inc. are turning rate-cut fever to their advantage by...
Olympic ad spending at record levels as streaming boom helps fuel demand
Yahoo Finance· 2 hours agoIn April, the network said it was on track to set a new record after already notching $1.2 billion...
Elon Musk’s X Activates Setting Allowing It to Train Grok AI on User Posts and Interactions by...
Variety via Yahoo Canada News· 2 hours agoX, the social network formerly known as Twitter owned by mega-billionaire tech mogul Elon Musk, has...
Bristol Myers Squibb Hurtles on Q2 Numbers
Baystreet· 2 hours agoThe pharmaceutical giant raised its full-year revenue forecast to an increase in the “upper end” of the low single-digit range. The company also raised its 2024 adjusted earnings guidance to ...
